hercessi - trastuzumab - strf injection, powder, lyophilized, for solution
(Trastuzumab-Strf)Accord Biopharma Inc.
HER2/neu Receptor Antagonist [EPC] class drugs
7 results
kanjinti - trastuzumab - anns injection, powder, lyophilized, for solution
(Trastuzumab-Anns)Amgen, Incmargenza - margetuximab - cmkb injection, solution, concentrate
(Margetuximab-Cmkb)Tersera Therapeutics Llcogivri - trastuzumab - dkst
(Trastuzumab-Dkst)Biocon Biologics Inc.ontruzant - trastuzumab injection, powder, lyophilized, for solution
(Trastuzumab)Organon LlcUsage: Ontruzant is indicated for adults with HER2-overexpressing breast cancer and metastatic gastric or gastroesophageal junction adenocarcinoma. It is used in various treatment regimens and as a single agent, with patient selection based on an FDA-approved companion diagnostic for trastuzumab products.perjeta - pertuzumab injection, solution, concentrate
(Pertuzumab)Genentech, Inc.Usage: PERJETA is a HER2/neu receptor antagonist indicated for adults with HER2-positive metastatic breast cancer, in combination with trastuzumab and docetaxel, as well as for neoadjuvant and adjuvant treatments of locally advanced or early stage breast cancer as part of a complete treatment regimen.trazimera - trastuzumab - qyyp
(Trastuzumab-Qyyp)Pfizer Laboratories Div Pfizer Inc